CDH1 and neoplasm: The expression of these tumor markers (except for E-cadherin) in the malignant tumor group was significantly higher than in the benign group and the healthy control group (p < 0.05), however, there were no significant differences between the benign mammary tumor group and the healthy control group (p > 0.05).